Listening: Novartis criticises new US drug pricing rules
On Thursday, Novartis reiterated its claim that the US pricing of its Entresto drug was “unconstitutional”. Prices set under the White House’s Inflation Reduction Act (IRA) will limit access to medicine, the Basel firm says.
This content was published on
2 minutes
Keystone-SDA
Français
fr
Novartis critique les nouveaux prix fixés aux USA pour Entresto
Original
The price-setting process is “not objective or transparent” and does not reflect the true value of a drug, Novartis wrote in a press releaseExternal link. For the Basel-based pharmaceutical giant, the new prices set under US President Joe Biden’s IRA will also have “long-lasting and devastating consequences for patients by limiting access to medicines now and in the future”.
Currently, US patients pay an average of $29 (CHF25.24) a month for Entresto, a drug to treat heart failure. The IRA, a wide-ranging program of energy transition and social reform, plans to lower the prices of ten drugs for treating serious illnesses – including Entresto – after January 2026.
Under pressure, and despite strong reluctance, several major pharmaceutical companies, including Novartis, agreed to take part in negotiations with Medicare, the health insurance scheme for the over-65s in the United States.
“We acceded to a “maximum fair price” for Entresto for 2026 only to avoid other untenable options including catastrophic fines or the removal of all our products from both Medicare and Medicaid,” Novartis said in its press release.
Adapted from French by DeepL/dos
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Culture
Wealth is not all: how gentrification in Zurich has led to housing shortage
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
Switzerland increasingly a target for people smuggling and trafficking
This content was published on
Switzerland is increasingly being targeted by organized crime. This also applies to commercial people smuggling, the fastest growing criminal market in Europe.
Swiss forests better equipped against storms 25 years after Lothar
This content was published on
Twenty-five years ago, Hurricane Lothar toppled trees like dominoes in Switzerland. Forests today are better prepared to cope with such an exceptional event, say experts.
This content was published on
The Locarno Film Festival is considering moving from the beginning of August to the second half of July for its 80th edition in 2027.
Council of Europe head Alain Berset visits Georgia
This content was published on
The Secretary General of the Council of Europe, Alain Berset, is visiting Georgia, which has been rocked by a political crisis, from Wednesday.
Swiss politician who shot at Jesus faces criminal proceedings
This content was published on
The Zurich public prosecutor's office has opened criminal proceedings against politician Sanija Ameti. It is investigating whether she disrupted freedom of religion and worship.
Switzerland must be able to control immigration, says head of business federation
This content was published on
Switzerland must be able to control immigration itself if it "exceeds the tolerable limits", says Christoph Mäder, president of Economiesuisse, the Swiss Business Federation.
This content was published on
The film Reinas by Klaudia Reynicke, a Swiss-Peruvian-Spanish co-production, has missed out on an Oscar nomination for Best Foreign Film.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.